SMARCA5 and malignant colon neoplasm: The upregulation of circ-SMARCA5 in colon cancer cells resulted in the inhibition of the Wnt and YAP1 pathways, while miR-552 overexpression restored Wnt and YAP1 pathway activities, suggesting that circ-SMARCA5 had anti-cancer properties11.